Showing 168 results
-
Media Release /The Philippine Food and Drug Administration (FDA) has approved inclisiran for the treatment of hypercholesterolemia or mixed dyslipidemia.Inclisiran is a first-in-class small interfering RNA (siRNA)…
-
Media Release /High levels of low-density lipoprotein cholesterol (LDL-C or bad cholesterol) can lead to an accumulation of fatty plaques in the arteries that supply blood to the heart, lungs, and brain. Clogging…
-
Media Release /The first-ever Think Pink Awards on Outstanding Stories on Breast Cancer was co-organized by the Philippine Press Institute (PPI) in partnership with Novartis and the ICanServe Foundation, coinciding…
-
Media Release /Novartis Healthcare Philippines and AC Health have launched their Integrated Cardiovascular and Cancer Care partnership that aims to broaden access to innovative medicines for breast cancer, heart…
-
Media Release /Photo shows (from left): Ms. Christine Fajardo, Communications & Engagement Head, Novartis Healthcare Philippines; Dr. Alfonso Nuñez III, Chief, East Avenue…
-
Media Release /Patient navigators took center stage at the plenary session supported by Novartis Healthcare Philippines during the Philippine National Cancer Summit 2024. Entitled “Beyond the Pink Ribbon:…
-
Media Release /The 4th annual Alliance & Partnerships for Patient Innovation & Solutions (APPIS) Summit will take place on Tuesday, March 19, and Wednesday, March 20, 2024.Co-created by the APPIS 2024…
-
Media Release /In line with its mission of extending and improving the lives of those with breast cancer, Novartis is supporting the 5th Philippine National Cancer Summit (PNCS) scheduled on 29 February to 01 March…
-
Media Release /Key stakeholders expressed their commitment to work together in addressing barriers to breast cancer care in the country during the final roundtable of the “Inspiring Conversations on Breast Cancer…
